Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 07:49, 13 June 2024 JDoerfler talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=doi:10.1016/j.ijrobp.2009.08.013 |A...")
• 14:14, 11 June 2024 JDoerfler talk contribs created page Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck (Created page with "{{Reference |Reference=Publication: Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=?...")
• 14:03, 11 June 2024 JDoerfler talk contribs created page Publication: Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck (Created page with "{{Publication |Title=Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck |Topic=Selenium |Author=Mix, M; Singh, AK; Tills, M; Dibaj, S; Groman, A; Jaggernauth, W; Rustum, Y; Jameson, M B |Year=2015 |Journal=World journal of clinical oncology |DOI=10.5306/wjco.v6.i5.166 |Authors Abstract=AIM: To investigate whether selenomethionine (SLM) reduces mucositis incidence in patie...")
• 06:54, 11 June 2024 JDoerfler talk contribs created page Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 (Created page with "{{Reference |Reference=Publication: Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N r...")
• 13:17, 10 June 2024 JDoerfler talk contribs created page Publication: Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 (Created page with "{{Publication |Title=Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 |Topic=Selenium |Author=Karp, D. D.; Lee, S. J.; Keller, S. M.; Wright, G. S.; Aisner, S.; Belinsky, S. A.; Johnson, D. H.; Johnston, M. R.; Goodman, G.; Clamon, G.; Okawara, G.; Marks, R.; Frechette, E.; McCaskill-Stevens, W.; Lippman, S. M.; Ruckdeschel, J.; Khuri, F. R. |Y...")
• 08:25, 10 June 2024 JDoerfler talk contribs created page Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial (Created page with "{{Reference |Reference=Publication: The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analy...")
• 08:22, 10 June 2024 JDoerfler talk contribs created page Publication: The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial (Created page with "{{Publication |Title=The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial |Topic=Selenium |Author=Jahangard-Rafsanjani, Z.; Gholami, K.; Hadjibabaie, M.; Shamshiri, A.R.; Alimoghadam, K.; Sarayani, A.; Mojtahedzadeh, M.; Ostadali-Dehaghi, M.; Ghavamzadeh, A. |Year=2013 |Journal=Bone marrow transplantation |DOI=10.1038/bmt.2012.250 |Authors Abstract=Oral mucositis (OM) is a complication of high-dose...")
• 11:26, 7 June 2024 JDoerfler talk contribs deleted page Tj (content was: "{{Publication |Title=xfj |Topic=FactorAF2 |Author=hf |Year=2015 |Journal=cgj |Authors Abstract=Background }}", and the only contributor was "JDoerfler" (talk))
• 11:25, 7 June 2024 JDoerfler talk contribs created page Tj (Created page with "{{Publication |Title=xfj |Topic=FactorAF2 |Author=hf |Year=2015 |Journal=cgj |Authors Abstract=Background }}")
• 11:24, 7 June 2024 JDoerfler talk contribs created page Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial (Created page with "{{Reference |Reference=Publication: Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N rand...")
• 10:46, 7 June 2024 JDoerfler talk contribs created page Publication: Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial (Created page with "{{Publication |Title=Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial |Topic=Selenium |Author=Goossens, M.E.; Zeegers, M.P.; van Poppel, H.; Joniau, S.; Ackaert, K.; Ameye, F.; Billiet, I.; Braeckman, J.; Breugelmans, A.; Darras, J.; Dilen, K.; Goeman, L.; Tombal, B.; Van Bruwaene, S.; Van Cleyenbreugel, B.; Van der Aa, F.; Vekemans, K.; Buntinx, F. |Year=2016 |Journal=E...")
• 09:31, 7 June 2024 JDoerfler talk contribs created page Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients (Created page with "{{Reference |Reference=Publication: Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specific...")
• 09:29, 7 June 2024 JDoerfler talk contribs created page Publication: Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients (Created page with "{{Publication |Title=Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients |Topic=Selenium |Author=Büntzel, J.; Riesenbeck, D.; Glatzel, M.; Berndt-Skorka, R.; Riedel, T.; Mücke, R.; Kisters, K.; Schönekaes, K.G.; Schäfer, U.; Bruns, F.; Micke, O. |Year=2010 |Journal=Anticancer research |Authors Abstract=Objective: The substitution of selenium activates the selenium-dependent enzy...")
• 07:33, 4 June 2024 JDoerfler talk contribs created page Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients (Created page with "{{Reference |Reference=Publication: Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |...")
• 07:31, 4 June 2024 JDoerfler talk contribs created page Publication: Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients (Created page with "{{Publication |Title=Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients |Topic=Selenium |Author=I. A. Asfour; S. El Shazly; M. H. Fayek; H. M. Hegab; S. Raouf; M. A. R. Moussa |Year=2006 |Journal=Biological trace element research |DOI=10.1385/bter:110:1:19 |Authors Abstract=The present study was undertaken to explore the effect of the administration of high doses of sodium selenite on apoptosis in polym...")
• 06:26, 4 June 2024 JDoerfler talk contribs created page Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer (Created page with "{{Reference |Reference=Publication: Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=?...")
• 06:25, 4 June 2024 JDoerfler talk contribs created page Publication: Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer (Created page with "{{Publication |Title=Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer |Topic=Selenium |Author=Stratton, M. S.; Algotar, A. M.; Ranger-Moore, J.; Stratton, S. P.; Slate, E. H.; Hsu, C.-H.; Thompson, P. A.; Clark, L. C.; Ahmann, F. R. |Year=2010 |Journal=Cancer prevention research |DOI=10.1158/1940-6207.CAPR-09-0143 |Authors Abstract=The Nutritional Prevention of Cancer tr...")
• 08:42, 27 May 2024 JDoerfler talk contribs deleted page Jatoi et al. (2002) : Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study (content was: "{{Publication |Title=Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study |Topic=Cannabinoids |Author=Jatoi et al. |Year=2002 |Journal=Journal of clinical oncology : official journal of the American Society of Clinical Oncology |DOI=https://scholar.google.de/scholar?hl=de&as_sdt=0%2C5&q=Dronabinol+versus+megestrol+acetate+versus+combination+therapy+for+cancer-associated+anorexia%3A+a+North+Ce...")
• 08:41, 27 May 2024 JDoerfler talk contribs deleted page BeispielStudie3 (content was: "{{Publication |Title=asd |Topic=Chronomedicine and Oncology |Author=ads |Year=1999 |Journal=asd |DOI=asd }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=Prospective |Centralized=Multicentric |Blinding=Single |Is randomized=Yes |Number of arms=3 }} =Study characteristics= {{RCT study general properties |Inclusion criteria participants=asd |Exclusion criteria pa...", and the only contributor was "Cotto" (talk))
• 08:41, 27 May 2024 JDoerfler talk contribs deleted page BeispielStudie2 (content was: "{{Reference Overview |Publication={{#show:{{SUBJECTPAGENAME}} | ?Reference}} }} {{Reference |Reference=Publication name without commas }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=Retrospective |Centralized=Multicentric |Blinding=Single |Is randomized=Yes |Number of arms=4 }} =Study characteristics= {{RCT study general properties |Inclusion criteria particip...", and the only contributor was "Cotto" (talk))
• 08:41, 27 May 2024 JDoerfler talk contribs deleted page BeispielStudie1 (content was: "{{Reference Overview |Publication={{#show:{{SUBJECTPAGENAME}} | ?has subobject.Reference#-}} }} {{#subobject:| |Reference=Otto et al., 2019, Understanding, categorizing and predicting semantic image-text relations }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=Prospective |Centralized=Monocentric |Is randomized=No |Number of arms=4 }} =Study characteristics=...", and the only contributor was "Cotto" (talk))
• 08:41, 27 May 2024 JDoerfler talk contribs deleted page Versuch Dienstag (content was: "{{Reference |Reference=Mustermann (2024): Effects of Trying too hard }} =Brief summary= =Search Strategy= {{Search Strategy |Search period start=June 2023 |Search period end=June 2024 |Number of databases=4 |Databases used=? }} =Study Design= {{Study Design (SR) |Meta analysis=No |Type of included studies=RCT, SR |Number of included studies=200, für uns relevant 20 |Inclusion cr...", and the only contributor was "DDeel" (talk))
• 08:40, 27 May 2024 JDoerfler talk contribs deleted page Versuch Di (content was: "{{Reference |Reference=Mustermann (2024): Effects of Trying too hard }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=Retrospective |Centralized=Multicentric |Blinding=Single |Is randomized=Yes |Cross-over=Yes |Number of arms=2 }} =Study characteristics= {{RCT study general properties |Inclusion criteria participants=? |Exclusion criteria participants=? |Number of randomized participants=200 |Participants PP=180 |Participants ITT=200 |Countries of data col...")
• 08:40, 27 May 2024 JDoerfler talk contribs deleted page Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain. Journal of pain and symptom management (content was: "{{Publication |Title=Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain |Topic=Cannabinoids |Author=Lichtmann et al. |Year=2018 |Journal=Journal of pain and symptom management |DOI=https://doi.org/10.1016/j.jpainsymman.2017.09.001 }} =Brief summary= Lichtma...", and the only contributor was "Cotto" (talk))
• 08:39, 27 May 2024 JDoerfler talk contribs deleted page Dasdasdasd (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria participants=? |Exclusion criteria participants=? |Number of randomized participants=-999 |Participants PP=-999 |Participants I...", and the only contributor was "Cotto" (talk))
• 08:39, 27 May 2024 JDoerfler talk contribs deleted page Cfti (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Number of arms=? }} =Study characteristics= {{RCT study general properties |Number of randomized participants=? |Outcome timeline=? |Level of evidence=? }} =Characteristics of participants= {{Characteristics of participants |Ty...", and the only contributor was "JDoerfler" (talk))
• 08:39, 27 May 2024 JDoerfler talk contribs deleted page Asddd (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |N in PP analysis=-999 |N in ITT analysis=-999 |Countries of data collection=? |Outc...", and the only contributor was "Cotto" (talk))
• 08:39, 27 May 2024 JDoerfler talk contribs deleted page Asdasddd (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |N in PP analysis=-999 |N in ITT analysis=-999 |Countries of data collection=? |Outc...", and the only contributor was "Cotto" (talk))
• 08:38, 27 May 2024 JDoerfler talk contribs deleted page Uahdoaslkdasd (content was: "{{Reference |Reference=? }} =Brief summary= =Search Strategy= {{Search Strategy |Number of databases=-999 |Databases used=? }} =Study Design= {{Study Design (SR) |Meta analysis=No |Type of included studies=? |Number of included studies=-999 |Inclusion criteria=? |Exclusion criteria=? |Number of examined persons=-999 |Overall Drop-out=? |Countries of data collection=? |Level of ev...", and the only contributor was "Cotto" (talk))
• 08:38, 27 May 2024 JDoerfler talk contribs deleted page Ssssssssssdddddddddddddd (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |N in PP analysis=? |N in ITT analysis=? |Countries of data collection=? |Outcome ti...", and the only contributor was "Cotto" (talk))
• 08:38, 27 May 2024 JDoerfler talk contribs deleted page Sega (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria participants=? |Exclusion criteria participants=? |Number of randomized participants=-999 |Participants PP=-999 |Pa...", and the only contributor was "JDoerfler" (talk))
• 08:38, 27 May 2024 JDoerfler talk contribs deleted page SRLöschen (content was: "{{Reference |Reference=? }} =Brief summary= =Search Strategy= {{Search Strategy |Number of databases=? |Databases used=? }} =Study Design= {{Study Design (SR) |Meta analysis=No |Type of included studies=? |Level of evidence=? }} =Study characteristics= {{SR Study |Types of cancer=? |Cancer stage=? |Current cancer therapy=? }} =Arms= {{Arm Overview}} {{Arm |Arm type=? |Number of participants (arm)=? |Drop-out=? |Dosage and regime=? |Duration in days=? |Side effects=? |Inter...")
• 08:38, 27 May 2024 JDoerfler talk contribs deleted page Nfui4hui (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |N in PP analysis=? |N in ITT analysis=? |Countries of data collection=? |Outcome ti...", and the only contributor was "DDeel" (talk))
• 08:37, 27 May 2024 JDoerfler talk contribs deleted page Löschen3 (content was: "{{Reference |Reference=? }} =Brief summary= =Search Strategy= {{Search Strategy |Number of databases=-999 |Databases used=? }} =Study Design= {{Study Design (SR) |Meta analysis=No |Type of included studies=? |Number of included studies=-999 |Inclusion criteria=? |Exclusion criteria=? |Number of examined persons=-999 |Overall Drop-out=? |Countries of data collection=? |Level of ev...", and the only contributor was "Cotto" (talk))
• 08:37, 27 May 2024 JDoerfler talk contribs deleted page Löschen2 (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=? }} =Study characteristics= {{RCT study general properties |Number of randomized participants=? |Outcome timeline=? |Level of evidence=? }} =Characteristics of participants= {{Characteristics of participants...", and the only contributor was "Cotto" (talk))
• 08:37, 27 May 2024 JDoerfler talk contribs deleted page Löschen 15 (content was: "{{Reference |Reference=? }} =Brief summary= =Search Strategy= {{Search Strategy |Number of databases=-999 |Databases used=? }} =Study Design= {{Study Design (SR) |Meta analysis=No |Type of included studies=? |Number of included studies=-999 |Inclusion criteria=? |Exclusion criteria=? |Number of examined persons=-999 |Overall Drop-out=? |Countries of data collection=? |Level of ev...", and the only contributor was "DDeel" (talk))
• 08:37, 27 May 2024 JDoerfler talk contribs deleted page Bittelöschen (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=? }} =Study characteristics= {{RCT study general properties |Number of randomized participants=? |Outcome timeline=? |Level of evidence=? }} =Characteristics of participants= {{Characteristics of participants...", and the only contributor was "Cotto" (talk))
• 08:36, 27 May 2024 JDoerfler talk contribs deleted page Asdasdd (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |Number of randomized participants=-999 |N in PP analysis=-999 |N in ITT analysis=-999 |Countries of da...", and the only contributor was "Cotto" (talk))
• 08:36, 27 May 2024 JDoerfler talk contribs deleted page Asdasd (content was: "{{Reference |Reference=? }} =Brief summary= =Search Strategy= {{Search Strategy |Number of databases=-999 |Databases used=? }} =Study Design= {{Study Design (SR) |Meta analysis=No |Type of included studies=? |Number of included studies=-999 |Inclusion criteria=? |Exclusion criteria=? |Number of examined persons=-999 |Overall Drop-out=? |Countries of data collection=? |Level of ev...", and the only contributor was "Cotto" (talk))
• 08:36, 27 May 2024 JDoerfler talk contribs deleted page Alkjshdlasd (content was: "{{Reference |Reference=? }} =Brief summary= =Search Strategy= {{Search Strategy |Number of databases=-999 |Databases used=? }} =Study Design= {{Study Design (SR) |Meta analysis=No |Type of included studies=? |Number of included studies=-999 |Inclusion criteria=? |Exclusion criteria=? |Number of examined persons=-999 |Overall Drop-out=? |Countries of data collection=? |LoE=? }} =R...", and the only contributor was "Cotto" (talk))
• 08:36, 27 May 2024 JDoerfler talk contribs deleted page Ajshdkjashdkjashd (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |N in PP analysis=-999 |N in ITT analysis=-999 |Countries of data collection=? |Outc...", and the only contributor was "Cotto" (talk))
• 08:36, 27 May 2024 JDoerfler talk contribs deleted page Ahsdlasd (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=?123 |Exclusion criteria=?456 |Number of randomized participants=-999 |Participants PP=-999 |Participants ITT=-999 |Countries o...", and the only contributor was "Cotto" (talk))
• 08:36, 27 May 2024 JDoerfler talk contribs deleted page Aasddddddddddd (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |N in PP analysis=-999 |N in ITT analysis=-999 |Countries of data collection=? |Outc...", and the only contributor was "Cotto" (talk))
• 08:35, 27 May 2024 JDoerfler talk contribs deleted page Löschen (content was: "{{Reference |Reference=? }} =Brief summary= =Search Strategy= {{Search Strategy |Number of databases=-999 |Databases used=? }} =Study Design= {{Study Design (SR) |Meta analysis=No |Type of included studies=? |Number of included studies=? |Number of examined persons=-999 |Level of evidence=? }} =Study characteristics= {{SR Study |Types of cancer=? |Cancer stage=? |Current cancer...", and the only contributor was "Cotto" (talk))
• 08:35, 27 May 2024 JDoerfler talk contribs deleted page Dtmzk7 (content was: "{{Reference |Reference=? }} =Brief summary= =Search Strategy= {{Search Strategy |Number of databases=-999 |Databases used=? }} =Study Design= {{Study Design (SR) |Meta analysis=No |Type of included studies=? |Number of included studies=-999 |Inclusion criteria=? |Exclusion criteria=? |Number of examined persons=-999 |Overall Drop-out=? |Countries of data collection=? |LoE=? }} =R...", and the only contributor was "DDeel" (talk))
• 08:34, 27 May 2024 JDoerfler talk contribs deleted page Aaaaaaaa (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=? }} =Study characteristics= {{RCT study general properties |Number of randomized participants=? |Outcome timeline=? |Level of evidence=? }} =Characteristics of participants= {{Characteristics of participants |Types of cancer=? |Cancer stage=? |Current cancer therapy=? |Included sex=? }} =Arms= {{Arm Ove...")
• 08:34, 27 May 2024 JDoerfler talk contribs deleted page Aaa (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=? }} =Study characteristics= {{RCT study general properties |Number of randomized participants=? |Outcome timeline=? |Level of evidence=? }} =Characteristics of participants= {{Characteristics of participants...", and the only contributor was "Cotto" (talk))
• 13:52, 21 May 2024 JDoerfler talk contribs deleted page Publication: Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study (content was: "{{Publication |Title=thjsj |Topic=Ginger (also contains zerumbone) |Author=Uthaipaisanwong, A.; Oranratanaphan, S.; Musigavong, N. |Year=2020 |Journal=ftuke5 |Authors Abstract=? }}", and the only contributor was "JDoerfler" (talk))
• 13:51, 21 May 2024 JDoerfler talk contribs deleted page Uthaipaisanwong et al. (2020): Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study (content was: "{{Reference |Reference=Publication: Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT s...", and the only contributor was "JDoerfler" (talk))
• 13:15, 21 May 2024 JDoerfler talk contribs created page Uthaipaisanwong et al. (2020): Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study (Created page with "{{Reference |Reference=Publication: Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Sp...")